We just received data on a new analyst forecast for $VRNS. JP Morgan gave a rating of 'Overweight' for $VRNS.
$VRNS Analyst Ratings
Wall Street analysts have issued reports on $VRNS in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 09/24/2025
- Needham issued a "Buy" rating on 09/03/2025
- Wedbush issued a "Outperform" rating on 09/03/2025
- Morgan Stanley issued a "Overweight" rating on 09/02/2025
- B. Riley Securities issued a "Buy" rating on 08/26/2025
- Wells Fargo issued a "Overweight" rating on 08/11/2025
- UBS issued a "Buy" rating on 07/30/2025
To track analyst ratings and price targets for $VRNS, check out Quiver Quantitative's $VRNS forecast page.
$VRNS Price Targets
Multiple analysts have issued price targets for $VRNS recently. We have seen 15 analysts offer price targets for $VRNS in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Brian Essex from JP Morgan set a target price of $70.0 on 09/24/2025
- Matthew Hedberg from RBC Capital set a target price of $64.0 on 09/03/2025
- Mike Cikos from Needham set a target price of $70.0 on 09/03/2025
- Daniel Ives from Wedbush set a target price of $65.0 on 09/03/2025
- Hamza Fodderwala from Morgan Stanley set a target price of $66.0 on 09/02/2025
- Erik Suppiger from B. Riley Securities set a target price of $80.0 on 08/26/2025
- Fatima Boolani from Citigroup set a target price of $58.0 on 08/18/2025
$VRNS Insider Trading Activity
$VRNS insiders have traded $VRNS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $VRNS stock by insiders over the last 6 months:
- GUY MELAMED (CFO and COO) has made 0 purchases and 5 sales selling 110,386 shares for an estimated $6,264,165.
- DEN BOSCH FRED VAN has made 0 purchases and 2 sales selling 9,000 shares for an estimated $465,240.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNS Hedge Fund Activity
We have seen 181 institutional investors add shares of $VRNS stock to their portfolio, and 207 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. added 2,195,730 shares (+inf%) to their portfolio in Q2 2025, for an estimated $111,433,297
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,550,178 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $78,671,533
- UBS GROUP AG removed 1,272,047 shares (-53.1%) from their portfolio in Q2 2025, for an estimated $64,556,385
- BANK OF MONTREAL /CAN/ removed 1,085,654 shares (-70.0%) from their portfolio in Q2 2025, for an estimated $55,096,940
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,084,651 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,874,132
- VOYA INVESTMENT MANAGEMENT LLC added 1,004,476 shares (+43.3%) to their portfolio in Q2 2025, for an estimated $50,977,157
- POLAR CAPITAL HOLDINGS PLC removed 1,003,524 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $40,592,545
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
